Information Provided By:
Fly News Breaks for September 14, 2017
CELG
Sep 14, 2017 | 19:31 EDT
RBC Capital analyst Brian Abrahams started Celgene with a Top Pick rating and $176 price target. The company's "best-in-class medium-term growth prospects are substantially undervalued relative to peers," the analyst tells investors in a research note.
News For CELG From the Last 2 Days
There are no results for your query CELG